Introduction

27
Oral biofilm communities are naturally formed on tooth surfaces and are associated with diseases such as 28 caries, gum inflammation (gingivitis) and degradation of periodontal tissues (periodontitis) (5-6). These 29 diseases are mainly caused by those biofilm-organisms that exhibit phenotypic traits capable of surviving 30 in adverse environmental conditions. For example, Streptococcus mutans undergoes an acid tolerant 31 response to adapt and survive the acidic conditions provoked by excess sugar intake (3, 11). This 32 important phenotypic trait of S. mutans is directly linked with caries development (5, 12). Therefore, 33 novel approaches for developing oral care products, such as dentifrices and mouthwashes, rely on 34 targeting these highly adaptable oral organisms and to block their key mechanisms of phenotypic 35 variation. One major step forward in achieving this goal has been the development of antimicrobial 36 systems that could effortlessly diffuse all across biofilm structures (4). For this purpose, there has been an 37 increasing interest in developing nanoscale systems to be used as biological carriers within biofilms. Of 38 special interest are those nanoscale systems developed from natural polymers, e.g. chitosan (10). Chitosan 39 is obtained by deacetylation of chitin and is used in biomedical applications due to its high 40 biocompatibility and antimicrobial properties (8). In the present study we formulated nanoparticles of 41 
Formulation of chitosan nanoparticles 46
The first step was to formulate nanoparticles using various chitosans with different degrees of 47 deacetylation (DD) and molecular weights (Mw) (Bioneer A/S and NovaMatrix, Norway). Fig. 1 shows 9 48 different chitosans used in this study distributed according to their DD and Mw. These chitosans were 49 categorized into three groups: (A) high DD and low Mw, (B) high DD and high Mw, and (C) low DD and 50 low Mw. 51
Chitosan nanoparticles were created by ion gelation with polyanionic sodium triphosphate (TPP) (Fig. 2a ) 52 (13). Since one of the reported problems with chitosan preparations has been its low solubility under 53 neutral pH conditions, we further developed the system to produce stable nanoparticle at neutral pH. 54 Nanoparticle assemblies were generally formulated by dissolving chitosan in acetic acid buffer (1mg/ml) 55 and by adding 100 µl of this mixture drop-wise under vigorous stirring, to a premixed solution composed 56 of 50 µl of TPP solution (0.1%) in water and 500 µl PBS buffer (pH 7.4). The mass ratio of chitosan to 57 TPP was kept constant (2:1). The final pH of the solution was around 5 and was adjusted to 7 by the 58 addition of 2M NaOH. The nanoparticle solution was equilibrated at room temperature for an hour by 59 mixing. Particle size distribution and zeta potential was further characterized in a Malvern ZetasizerNano 60
ZSinstrument to measure particle size distributions and zeta potential in different media. Scanning 61 electron microscopy (SEM) shown in Fig. 2b was also used to visualize particles in deionised water 62 before mixing with media. The particle size distribution in water was relatively narrow with some batch 63 to batch variation. After mixing with media the size distribution broadened and was between 20-1000nm 
Exposure of S. mutans biofilms to chitosan nano-particles 67
Biofilms were formed in the flow-chamber system µ-Slide VI (Integrated BioDiagnostics) as previously 68 described (2). In brief, 120 µl of a washed suspension of Streptococcus mutans UA159 in mid-69 exponential growth (OD 600 = 0.4±0.1) were inoculated in the mini-flow chamber slides and incubated in 70 an atmosphere of 5 % CO 2 at 37 °C for 24 h under static conditions. Flow-chambers were rinsed with 71 PBS to remove non-adherent cells. S. mutans biofilms were then exposed to the different chitosan/TPP 72 nanoparticle formulations diluted in TH medium at a ratio of 1:1. Ratios of 1:4 and 1:10 were also tested. 73
A solution of TPP (0.1%) in PBS was used as control. Flow cells were incubated for 2 h in an atmosphere 74 of 5 % CO 2 at 37 °C. Antimicrobial activity was assessed using the BacLight Bacterial Viability kit for 75 microscopy (LIVE/DEAD) (Invitrogen Ltd., Paisley, UK). The fluorescence from stained cells was 76 viewed using an inverted confocal scanning laser microscope, Eclipse TE2000 (Nikon, Tokyo, Japan), 77 where ten randomly selected image stack-sections were imaged in each biofilm sample. Image stack-78 sections were composed of ten images, each taken with a variation of 2 µm along the z-position. Images 79 were acquired with a 60x oil immersion objective and digitalized by the software EZ-C1 v.3.40 build 691 80 (Nikon, Tokyo, Japan) at a resolution of 512 x 512 pixels and with a zoom factor of 1.0, giving a final 81 pixel resolution of 0.42 µm/pixel. Individual biofilm images covered an area of 0.05 mm 2 per field of 82 view. Experiments were done in three triplicate sets of biofilms each set having its own unique total cell 83 count. CSLM images were analyzed to produce information of the total biofilm population as well as the 84 independent subpopulations represented by red and green fluorescent colors by using the software 85 bioImage_L (1). The structure and spatial differences in green (viable) and red (damaged) biofilm 86 subpopulations were characterized by three-dimensional analysis where parameters such as biovolume 87 nanoparticles no significant difference in the structure of biofilms was registered. However, the effect of 94 the tested nanoparticle formulations gave strong differences in the level of cell membrane damage (cells 95 stained red with LIVE/DEAD) as compared with the negative TPP control (see representative 3D biofilm 96 reconstructions in Fig. 3) . The ratio to which the chitosan nanoparticles were mixed in the medium didn't 97
show to have an effect in their antimicrobial activity (data not shown). 98
The representative nanoparticle preparations comprising chitosans with low molecular weight, Groups A 99 and C, showed the highest antimicrobial activity at the various depths of the biofilms formed by S. 100 mutans, (>95% of total cells damaged). These results indicated that the differences in the levels of 101 deacetylation in Group A (high DD) and Group C (low DD), did not seemingly affect the antimicrobial 102 activity of the chitosan nanoparticles. This lack of influence of deacetylation level may be due to free 103 amino groups being neutral at pH 7.. This may explain why our results differ from results in other studies 104 that found a positive correlation between the levels of deacetylation and the antimicrobial effect of 105 chitosan at a lower pH (7). By contrast, we observed a clear tendency between the molecular weight of 106 the chitosan and the effect on the membrane integrity of S. mutans with the lower molecular weight 107 chitosans showing the highest effect (Group A and C) and with progressively lower effect on membrane 108 integrity for larger molecular weights (Group B). Chitosan nanoparticles from Group B showed a 109 scattered effect in damaging the cell membrane of cells (20-25% of cells damaged) mainly at the upper 110 levels of the biofilms (> 15µm). At the levels closer to the substrate (< 4µm), chitosan nanoparticles 111 showed a slight effect in cell membrane damage (<5%). We do not have a clear picture of the mechanism 112 of the molecular weight effect on chitosan antimicrobial activity in nanoparticles. The heterogeneous 113 on September 23, 2017 by guest http://aem.asm.org/ Downloaded from 6/9 distribution of cell membrane damage at the upper levels of the biofilms and the lack of effect at the 114 substratum levels when using large Mw formulations, however, indicate a lower diffusive potential than 115 low Mw formulations which affected the membrane integrity of cells all across the biofilm. It is also 116 possible that the lower molecular weight nanoparticles have a systematically reduced number of TPP 117 molecules available per molecule and may thus be more susceptible to disaggregation in the biofilm. 118
Once homogenously distributed across the biofilms, chitosan particles can directly interact with bacterial 119 cells. Different mechanisms of interaction with bacteria have been proposed for chitosans (9). One 120 mechanism is based on the interaction between positively charged chitosan molecules and negatively 121 charged microbial cell membranes leading to the leakage of proteinaceous and other intracellular 122 constituents, however, at pH 7 free chitosan and the outer chitosan in the nanoparticle complexes are 123 expected to be neutral, however chitosan within the particle may retain charge. A second mechanism is 124 based on binding of chitosan with microbial DNA, in turn interfering with mRNA and protein synthesis, 125 which clearly requires entry of the chitosan into the cell. 126
127
Concluding remarks 128
This study showed antimicrobial activity of chitosan nanoparticles at neutral pH to have a strong trend 129 towards higher activity of particles formed from lower Mw chitosans. Futhermore, the effect of low 130 molecular weight formulations affected the cell membrane integrity of S. mutans in an homogenous 131 manner across the entire biofilm. It is expected that this system will greatly improve the uniform delivery 132 of chitosan formulated as nano-particles through biofilm structures at neutral pH and that with 133 combination of other compounds it could aid targeting of strongly adaptable organisms in complex 134 biofilm systems. 135 
